Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso

Descrição

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbo phage PCH45 evades type I, but not type III, CRISPR–Cas
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Subcellular organization of viral particles during maturation of nucleus-forming jumbo phage
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity: Cell
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A Jumbo Formation in the Viral Game Plan
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Frontiers The Phage Nucleus and PhuZ Spindle: Defining Features of the Subcellular Organization and Speciation of Nucleus-Forming Jumbo Phages
de por adulto (o preço varia de acordo com o tamanho do grupo)